Page 6 - Pharma Sector

Drugmaker Sanofi India fourth quarter net profit at Rs 145.9 crore

Drug firm Sanofi India on Tuesday reported a net profit of Rs 145.9 crore for the March ended quarter.

Novartis Q1 sales, profit miss analyst expectations amid Covid-19 impact

Swiss drugmaker Novartis on Tuesday said first-quarter core net income fell 4%

Laurus Labs hits new high in subdued market, surges 30% in a month

The company is scheduled to meet on April 29, 2021, to consider and approve the audited financial results of the company for the financial year ended March 31, 2021

US respiratory portfolio to drive medium term sales growth for Cipla

In the domestic market, growth is expected to come from Covid-related drugs

Drug maker Caplin Steriles gets USFDA approval for an injection

The injection is used for short-term intravenous treatment of patients with acute decompensated heart failure

Glenmark Pharma hits 23-month high on Glenmark Life Sciences IPO plan

ICICI Securities believe this is a positive development for the company and will lead to value unlocking for the shareholder

Glenmark Pharma arm files paperwork for IPO with market regulator

Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed paperwork to go public

Pharmaceutical industry rebounds in March at 10.3% growth: Ind-Ra

This was led by volume growth of 1.6 per cent, price growth of 5.1 per cent and products launches at 3.6 per cent

New launches to prop sales recovery as GSK Pharma gets over Zinetac pain

Near-term gains may be limited given restrictions which will impact anti-infectives portfolio

This stock from Dolly Khanna's portfolio has rallied 121% so far in 2021

Dolly Khanna acquired 161,336 equity shares or 1.26 per cent stake in Neuland Lab during the quarter ended March 2021

Aarti Drugs gains 6% as board to consider buyback on March 19

In the past six months, the stock of Aarti Drugs has underperformed the market by falling 7 per cent as against a 29 per cent rally in the Sensex

Cummins India rides on exports, likely to gain as demand for power grows

Diesel engine maker projected to benefit as companies planning to build data centres seek power providers

Bharat Biotech's Covaxin gets authorisation for emergency use: V K Paul

So far 1.9 million people in the country have been given Covaxin, of whom 311 showed some side effects

Insider alleges Eli Lilly blocked her efforts to sound alarms on drug plant

Lilly is working closely with the FDA to address concerns about the factory,

PLI to drive capex in industrial sectors by 40-45 % in FY22: CRISIL report

India's GDP growth to be at 11 per cent in fiscal 2022, says report predicting two-phase economic recovery

Manufacturing to get $520-billion PLI push in next 5 years: PM Modi

Says govt aims to do away with more than 6,000 compliance requirements

A bitter pill: Domestic pharma market growth slides to 1.1% in February

Recovery slow, top drug firms post muted growth in February

Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla Gulf will be responsible for commercialisation of patented biosimilars of the biologic medicine brands -- Aflibercept, Ustekimumab,Denosumab and Golimumab.

Investors turn to pharma stocks amid market crash; Nifty Pharma gains 1.5%

Among individual stocks, Lupin zoomed 3.4 per cent in the intra-day trade and hit a high of Rs 1,060, Sun Pharmaceuticals advanced 2 per cent, and Dr Reddy's Labs gained 1.7 per cent.

Govt working to improve ease of doing biz in pharma sector: Minister

The government is continuously working to reduce regulatory compliance burden on the pharma industry in a bid to improve ease of doing business in the country, Union Minister for Chemicals & Fertilisers D V Sadananda Gowda said on Thursday. Addressing the inaugural session of 'The India Pharma 2021 & India Medical Device 2021' event here, the minister also emphasised that the domestic pharma industry has the capability to achieve the target of USD 130 billion turnover by 2030. "Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the country. Vigorous effort is on to reduce the regulatory compliance burden on the (pharma) industry," Gowda said. Minister of State for Chemicals and Fertilisers Mansukh Mandaviya said that reforms are being undertaken by the government especially in the pharmaceutical sector. "In ease of doing business we have reached 79thposition now from the earlier 145. In the pharma ..